UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Special] ‘Healthcare policies fail to support long-term fight against Covid-19’
by Song Soo-youn/Kim Eun-young
2020-06-04 15:55
‘Blood test can detect Alzheimer’s early’
by Park Gi-taek
2020-06-04 15:40
Greater Seoul remains jittery over sporadic, silent spreads
by Shim Hyun-tai
2020-06-04 14:38
MedPacto to test Vactosertib for treating NSCLC
by Lee Han-soo
2020-06-04 12:43
Korea to spend ₩1 trillion on fight against infectious diseases
by Shim Hyun-tai
2020-06-03 18:18
라인
Dupixent to provide new treatment options for asthma patients
by Lee Han-soo
2020-06-03 17:54
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
by Shim Hyun-tai
2020-06-03 17:20
New plasma-based method found to treat refractory blood cancer
by Lee Han-soo
2020-06-03 16:29
Seoul OKs special import of remdesivir as Covid-19 treatment
by Kim Yun-mi
2020-06-03 16:05
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
by Lee Han-soo
2020-06-03 16:05
라인
Korea confirms Covid-19 candidate drug’s effect through weasels
by Kwak Sung-sun
2020-06-03 16:05
‘KOEDC to broaden drug accessibility for patients with rare diseases’
by Kim Yun-mi
2020-06-03 12:37
Unrelenting church-linked infections raise worries about new viral wave
by Shim Hyun-tai
2020-06-03 12:34
‘Mental, behavioral disorders’ social costs larger than their medical expense’
by Shim Hyun-tai
2020-06-02 18:28
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
by Shim Hyun-tai
2020-06-02 17:14
라인
CDK 4/6 inhibitor market to heat up on insurance benefits
by Lee Han-soo
2020-06-02 17:13
‘54% of MERS survivors had mental illness even 1 year after recovery’
by Choi Gwang-seok
2020-06-02 15:38
‘Covid-19 heroes? Nurses worry about pay cuts’
by Song Soo-youn
2020-06-02 15:33
Resurge of church-linked virus cases dims outlook for broader school reopening
by Shim Hyun-tai
2020-06-02 14:45
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
by Kim Yun-mi
2020-06-02 11:27
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top